STATE STREET CORP - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 193 filers reported holding DENALI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$88,200,017
-33.1%
4,275,328
-4.3%
0.01%
-28.6%
Q2 2023$131,865,169
+24.7%
4,468,491
-2.7%
0.01%
+16.7%
Q1 2023$105,785,130
-60.8%
4,591,389
-52.6%
0.01%
-25.0%
Q4 2022$269,523,952
+109.5%
9,691,620
+131.2%
0.01%0.0%
Q3 2022$128,659,000
+16.6%
4,192,228
+11.8%
0.01%
+14.3%
Q2 2022$110,383,000
-10.3%
3,750,700
-2.0%
0.01%
+16.7%
Q1 2022$123,108,000
-8.8%
3,826,792
+26.4%
0.01%0.0%
Q4 2021$135,030,000
-4.3%
3,027,571
+8.2%
0.01%
-14.3%
Q3 2021$141,166,000
-22.4%
2,798,134
+20.6%
0.01%
-30.0%
Q2 2021$182,017,000
+58.1%
2,320,460
+15.1%
0.01%
+42.9%
Q1 2021$115,152,000
-33.5%
2,016,667
-2.4%
0.01%
-36.4%
Q4 2020$173,138,000
+114.2%
2,067,073
-8.4%
0.01%
+83.3%
Q3 2020$80,818,000
+48.9%
2,255,599
+0.5%
0.01%
+50.0%
Q2 2020$54,291,000
+83.5%
2,245,280
+32.9%
0.00%
+33.3%
Q1 2020$29,588,000
+6.0%
1,689,756
+5.5%
0.00%
+50.0%
Q4 2019$27,910,000
+14.4%
1,602,182
+0.6%
0.00%0.0%
Q3 2019$24,391,000
-40.8%
1,592,093
-19.8%
0.00%
-33.3%
Q2 2019$41,230,000
+6.0%
1,986,023
+18.6%
0.00%0.0%
Q1 2019$38,883,000
+23.5%
1,674,551
+9.9%
0.00%0.0%
Q4 2018$31,477,000
+62.5%
1,523,584
+70.9%
0.00%
+200.0%
Q3 2018$19,375,000
+333.3%
891,327
+204.1%
0.00%
Q2 2018$4,471,000
+70.9%
293,124
+120.6%
0.00%
Q1 2018$2,616,000132,8480.00%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Crestline Management, LP 7,705,039$343,645,00025.68%
Casdin Capital, LLC 1,500,000$66,900,0001.89%
Flagship Pioneering Inc. 2,619,968$116,851,0001.81%
SECTORAL ASSET MANAGEMENT INC 189,600$8,456,0001.27%
Integral Health Asset Management, LLC 100,000$4,460,0001.23%
Temasek Holdings (Private) Ltd 5,369,487$239,479,0000.86%
Goldstream Capital Management Ltd 78,418$3,497,0000.86%
Yiheng Capital Management, L.P. 335,184$14,949,0000.76%
GILDER GAGNON HOWE & CO LLC 2,900,114$129,345,0000.74%
Artal Group S.A. 600,000$26,760,0000.73%
View complete list of DENALI THERAPEUTICS INC shareholders